EBOS Group

-7.17%

The EBOS Group is a leading Australasian distributor of healthcare, medical, and pharmaceutical products. It was founded in 1922 as a small pharmacy in Christchurch, New Zealand and has since grown into a multinational business with operations in Australia, New Zealand, and several countries in Southeast Asia.
The company’s core business is the distribution of healthcare products, including pharmaceuticals, medical devices, dental supplies, veterinary products, and consumer healthcare products. It also offers a range of logistics and supply chain services, as well as marketing and promotional support for its suppliers.
EBOS Group is listed on the Australian and New Zealand stock exchanges and is a constituent of the S&P/ASX 200 index.
In addition to its distribution and logistics services, the company also owns and operates a number of businesses in the healthcare sector. These include:
- Chemmart: a retail pharmacy chain in Australia.
- TerryWhite Chemmart: a partnership with TerryWhite Chemists, one of the largest retail pharmacy franchises in Australia.
- Symbion: a national healthcare services provider, including pharmaceutical wholesaling, logistics, and patient services.
- EBOS Healthcare: a provider of medical, surgical and personal healthcare products to hospitals and aged care facilities.
- Isomed: a national provider of radiopharmaceuticals and related services.
- ProPharma: a New Zealand-based provider of integrated healthcare solutions.
- Lumino The Dentists: a network of dental clinics in New Zealand.
EBOS Group has a strong commitment to sustainability, with initiatives in place to reduce its environmental impact and promote social responsibility. It has also been recognized for its leadership in gender diversity, with a Board of Directors that is almost 50% female and initiatives in place to promote women in leadership roles.
Overall, the EBOS Group is a well-established and diverse company with a strong presence in the healthcare industry in Australia, New Zealand, and beyond. It continues to grow and expand its range of products and services, while maintaining a focus on sustainability and social responsibility.

1. Market leader in healthcare, animal care, and medical products: EBOS Group is the largest and most diversified provider of medical, surgical, and pharmaceutical products in Australasia, serving both human and animal health.
2. Wide range of products and services: The company offers a comprehensive range of products and services, including medical, surgical, and pharmaceutical supplies, medical consumables, veterinary products, and equipment.
3. Long-standing history: EBOS Group was founded in 1922 and has a long history of providing quality products and services to the healthcare industry.
4. Strong brand portfolio: The company represents and distributes a wide range of well-known and trusted brands in the healthcare and animal care industries, such as Omron, Roche, Johnson & Johnson, and Pfizer.
5. Strong partnerships and relationships: EBOS Group has strong partnerships and relationships with customers, suppliers, and other key stakeholders, enabling it to provide a seamless and reliable supply chain.
6. Financial stability: EBOS Group is a financially stable and profitable company, with a track record of delivering strong financial results and consistent dividend payments to shareholders.
7. International presence: The company has a presence in multiple countries, including Australia, New Zealand, the United Kingdom, and Asia, enabling it to leverage global opportunities and diversify its revenue streams.
8. Commitment to sustainability: EBOS Group is committed to sustainable business practices and has implemented various initiatives to reduce its environmental impact, promote diversity and inclusion, and support the communities in which it operates.
9. Focus on innovation and technology: The company continuously invests in new technologies and processes to improve its operations and stay at the forefront of the rapidly evolving healthcare industry.
10. Experienced leadership: EBOS Group has a team of experienced and dedicated leaders who are committed to driving the company’s growth and success.

The EBOS Group is a leading healthcare and animal care products company based in New Zealand. Their business model is focused on three main areas:
1. Distribution: EBOS Group operates a large distribution network that supplies healthcare and animal care products to hospitals, pharmacies, veterinary clinics, and other healthcare providers. They have a strong presence in Australia and New Zealand, and also have operations in Asia and Europe.
2. Logistics: EBOS Group also offers logistics services, including warehousing, inventory management, and delivery, for healthcare and animal care products. This allows them to provide a seamless supply chain for their customers and ensure timely delivery of products.
3. Retail: The company has a retail division that operates pharmacies, medical equipment stores, and animal care centers in Australia and New Zealand. This allows them to directly reach consumers and provide a range of healthcare and animal care products and services.
In addition to these three core areas, the EBOS Group also has a strong focus on continuous growth and expansion through strategic acquisitions and partnerships. They prioritize long-term relationships with their suppliers, customers, and employees, and also invest heavily in innovation and technology to improve efficiency and drive future growth.

1. The EBOS Group is a leading Australasian healthcare company that has been in operation for over 90 years. It was founded in 1922 as a small pharmacy in Christchurch, New Zealand.
2. The company has grown significantly since its humble beginnings and now has operations in six countries across the Asia-Pacific region, including New Zealand, Australia, Singapore, Malaysia, Hong Kong, and China.
3. The name EBOS is an acronym for Eastern and Beddome, O’Connor and Selwyn, the surnames of the three founders of the company.
4. In the early days, the company’s main focus was on wholesaling and distributing pharmaceutical products. Over the years, it has diversified its operations and now offers a wide range of healthcare and medical products and services.
5. EBOS Group has a diverse portfolio of businesses, including pharmaceuticals, medical consumables, animal care, healthcare products, and logistics services.
6. In 2019, the company acquired the Australian pharmaceutical distributor and services provider, HPS, which significantly expanded its reach in the Australian market.
7. The EBOS Group is listed on both the Australian and New Zealand stock exchanges and is a member of the ASX 100 and NZX 50 indices.
8. In addition to its healthcare businesses, the company also has a strong commitment to social responsibility and sustainability. It has implemented various initiatives to reduce its environmental impact and support local communities.
9. In 2018, EBOS Group was named New Zealand’s Most Sustainable Large Company at the Deloitte Top 200 Awards.
10. The company has a strong focus on innovation and investing in emerging technologies to improve its business operations and better serve its customers. It has recently implemented state-of-the-art warehouse automation systems and developed a cloud-based customer ordering platform.